| Name | 5-(4-hydroxybenzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione |
|---|---|
| Synonyms | MHY-1685 |
| Description | MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C11H8N2O4 |
|---|---|
| Molecular Weight | 232.19 |
| Exact Mass | 232.04800 |
| PSA | 95.50000 |
| LogP | 0.79920 |
| Hazard Codes | T+ |
|---|---|
| HS Code | 2933540000 |
| HS Code | 2933540000 |
|---|---|
| Summary | 2933540000 other derivatives of malonylurea (barbituric acid); salts thereof。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0% |